Diagnosis, treatment, and prevention of vascular disorders using il-1.alpha. autoantibodies
CA 2617637 C · Owner: Bendtzen, Klaus · Inventors: Bendtzen, Klaus; Simard, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of detecting individuals at risk for atherosclerosis and related vascular diseases involving the detection of IL-l.alpha. autoantibodies as , well as therapeutic methods to prevent or treat atherosclerosis and related vascular disease by administering a pharmaceutical composition comprising ILl.alpha. autoantibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 26, 2006 and granted July 18, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 26, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.